Avid Bioservices Inc
NASDAQ:CDMO

  • LAST PRICE
    12.1600
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    12.0500/ 8
  • Ask / Lots
    12.1500/ 2
  • Open / Previous Close
    --- / 12.1600
  • Day Range
    ---
  • 52 Week Range
    4.0705
    12.4800
  • Volume
    2,164

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
CDMO
Avid Bioservices Inc
775.7M
-5.4x
---
TRDA
Entrada Therapeutics Inc
653.0M
10.9x
---
ADPT
Adaptive Biotechnologies Corp
690.2M
-3.5x
---
PRTA
Prothena Corporation PLC
726.6M
-5.4x
---
KMDA
Kamada Ltd
342.1M
19.2x
-22.48%
ARDX
Ardelyx Inc
1.2B
-15.9x
---
As of 2024-11-19

Company Information

Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization (CDMO) focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biologics. The Company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Its services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the Company provides a variety of process development activities, including cell line development, upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of its services ranges from standalone process development projects to full development and manufacturing programs through commercialization. Commercial biologics produced by it are distributed to over 90 countries.

Contact Information

Headquarters
14191 MYFORD ROADTUSTIN, CA, United States 92780
Phone
714-508-6100
Fax
714-838-5817

Executives

Independent Chairman of the Board
Joseph Carleone
President, Chief Executive Officer, Director
Nicholas Green
Chief Financial Officer
Daniel Hart
Chief Operations Officer
Richard Richieri
Vice President, General Counsel
Mark Ziebell

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$775.7M
Revenue (TTM)
$142.4M
Shares Outstanding
63.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.43
EPS
$-2.27
Book Value
$0.96
P/E Ratio
-5.4x
Price/Sales (TTM)
5.4
Price/Cash Flow (TTM)
---
Operating Margin
-14.66%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.